The activation of the mTOR pathway through the loss of the tuberous sclerosis complex 1 (TSC1)/TSC2 repressor complex seems to be a common pathogenic event in PEComas [24]. The gene discussed is MTOR; the disease is neoplasm with perivascular epithelioid cell differentiation.